peter attia glp-1 320 – AMA 64: New insights on agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape - The Drive 246 - AMA #45: Pros

Whilst not specifically licensed for menopausal weight gain, GLP-1 treatments may be prescribed for women meeting obesity treatment criteria during this life stage

Working with a Healthcare Professional: A Safer Path to Real Results When you meet with a healthcare professional, like a Midi clinician, to discuss weight loss goals, they take a comprehensive view of your overall health

All medications come from licensed 503A compounding pharmacies, and treatment is available in all 50 states without insurance or membership fees

115133 It is noteworthy that these data primarily derive from clinical trials in T2DM or obesity, and given the heterogeneity of metabolic disorders, caution should be exercised

So in addition to the weight reduction that were excited about, we know that theres protein loss, theres been some suggestion in the literature that there might be bone loss

doi:10.2147/CCID.S258834 31